We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
101
Pacific Biosciences
PACB
$339M
$8.69M 0.26%
340,143
-131,634
-28% -$3.9M
LNTH icon
102
Lantheus
LNTH
$6.58B
$8.65M 0.26%
336,926
-199,946
-37% -$5.22M
NEO icon
103
NeoGenomics
NEO
$2.1B
$8.58M 0.26%
+177,778
New +$8.23M
TKNO icon
104
Alpha Teknova
TKNO
$381M
$8.56M 0.26%
344,041
-5,959
-2% -$128K
APLS
105
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$8.54M 0.26%
+259,100
New +$14.6M
EVH icon
106
Evolent Health
EVH
$485M
$8.53M 0.26%
+275,000
New +$6.6M
WST icon
107
PUT
West Pharmaceutical
WST
$24.8B
$8.49M 0.26%
+20,000
New +$8.43M
GHRS icon
108
GH Research
GHRS
$2.04B
$8.38M 0.26%
380,045
-19,955
-5% -$406K
BIIB icon
109
CALL
Biogen
BIIB
$30.7B
$8.32M 0.25%
29,400
-600
-2% -$197K
GH icon
110
Guardant Health
GH
$22.1B
$8M 0.24%
64,023
-2,217
-3% -$263K
PEN icon
111
Penumbra
PEN
$12.9B
$8M 0.24%
+30,000
New +$8.06M
TELA icon
112
TELA Bio
TELA
$32.5M
$7.93M 0.24%
580,515
-177,009
-23% -$2.47M
LIVN icon
113
CALL
LivaNova
LIVN
$4.47B
$7.92M 0.24%
+100,000
New +$8.22M
SOPH icon
114
SOPHiA GENETICS
SOPH
$629M
$7.89M 0.24%
+450,010
New +$7.91M
MDXG icon
115
MiMedx Group
MDXG
$625M
$7.73M 0.24%
1,275,389
+105,089
+9% +$1.18M
LHDX
116
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$7.62M 0.23%
1,001,942
+601,942
+150% +$5.08M
IRTC icon
117
iRhythm Holdings
IRTC
$4.09B
$7.61M 0.23%
130,000
-10,000
-7% -$530K
TFX icon
118
PUT
Teleflex
TFX
$5.95B
$7.53M 0.23%
+20,000
New +$7.79M
NVCR icon
119
PUT
NovoCure
NVCR
$2.03B
$7.45M 0.23%
64,100
+29,400
+85% +$4.45M
GDX icon
120
PUT
VanEck Gold Miners ETF
GDX
$27.8B
$7.28M 0.22%
100,000
-95,100
-49% -$3.1M
MEDP icon
121
PUT
Medpace
MEDP
$16.8B
$7.06M 0.21%
+37,300
New +$6.8M
WBA
122
PUT
DELISTED
Walgreens Boots Alliance
WBA
$7.06M 0.21%
+150,000
New +$7.23M
EVH icon
123
CALL
Evolent Health
EVH
$485M
$6.86M 0.21%
+221,300
New +$5.31M
LMAT icon
124
PUT
LeMaitre Vascular
LMAT
$1.86B
$6.73M 0.2%
+126,800
New +$7.14M
PHG icon
125
PUT
Philips
PHG
$26.2B
$6.67M 0.2%
+181,593
New +$6.9M
3 4
5
6 7

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.